Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 8, 1999, Pages 825-831

  Polazzi, Elisabetta ^a   Levi, Giulio ^a   Minghetti, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS; Brain macrophages; Interferon Nuclear factor kB; Lipopolysaccharide; Transactivation

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; GENE INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROGLIA; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0032789741     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199908000-00005     Document Type: Article

References (43)

1. Epstein LG, Gendelman HE, Lipton SA. Human immunodeficiency virus-1 neuropathogenesis. In: Berger JR, and Levy RM, eds. AIDS and the nervous system. Second Edition. Philadelphia: Lippincott-Raven Publishers, 1997:59-75
2. Trillo-Pazos G, Everall IP. Neuronal damage and its relation to dementia in acquired immunodeficiency syndrome. Pathobiology 1996;64:295-307
3. Zheng J, Gendelman HE. The HIV-1 associated dementia complex: A metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 1997;10:319-25
4. Chang HK, Gallo RC, Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 tat protein. J Biomed Sci 1995;2:189-202
5. Ensoli B, Buonaguro L, Barillari G et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993;67: 277-87
6. Tardieu M, Hery C, Peudenier S, Boespflug O, Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 1992;32:11-17
7. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A. Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and cause neurotoxicity. J Virol 1995;37:373-80
8. Nath A, Psooy K, Martin C, et al. Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996;70:1474-80
9. Nath A and Gieger J. Neurobiological aspects of human immunodeficiency virus infection: Neurotoxic mechanisms. Prog Neurobiol 1998;54;19-33
10. New DR, Ma M, Epstein LG, Nath A, Gelbard HA. Human immunodeficiency virus type 1 tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997;3:168-73
11. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: Potentiation of neurotoxicity mediated by oxidative stress and implication for HIV-1 dementia. J Neurovirol 1998;4:281-90
12. Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A. Intraventricular injection of Human immunodeficiency virus type 1 tat protein causes inflammation, gliosis, apoptosis and ventricular enlargement. J Neurophatol Exp Neurol 1998;57:563-70
13. Philippon V, Vellutini C, Gambarelli D, et al. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: Involvement of cytokines. Virology 1994;205:519-29
14. Chen P, Mayne M, Power C, Nath A. The tat protein of HIV-1 induces tumor necrosis factor-α production. J Biol Chem 1997;272: 22385-88
15. Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998;95: 3117-21
16. Nathan C, and Xie QW. Nitric oxide synthases: Role, tolls and controls. Cell 1994;78:915-18
17. Minghetti L, Levi G. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 1998;54,99-125
18. Munoz-Fernandez M, and Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 1998;56:307-40
19. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995;181:735-45
20. Koka P, He K, Zack JA, et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J Exp Med 1995;182:941-52
21. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp 41. Science 1996;274:1917-21
22. Kong LY, Wilson BC, McMillian MK, Bing G, Hudson PM, Hong JS. The effect of the HIV-1 envelope protein gp 120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996;172:77-83
23. Levi G, Patrizio M, Bernardo A, Petrucci TC, Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci USA 1993;90:1541-45
24. Tracey WR. Spectrophotometric determination of nitrogen oxide using azo-dies. Neuroprotocols 1992;1:125-31
25. Minghetti L, Polazzi E, Nicolini A, Créminon C, Levi G. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J Neurochem 1996;66:1963-70
26. Minghetti L and Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem 1995;65:2690-98
27. Minghetti L, Nicolini A, Polazzi E, Créminon C, Maclouf J, Levi G. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and cyclooxygenase inhibitors. Glia 1997;19:152-60
28. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8
29. Mann DA, and Frankel AD. Endocytosis and targeting of exogenous HIV-1 tat protein. EMBO J 1991;10:1733-39
30. Efthymiadis A, Briggs LJ, Jans DA. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J Biol Chem 1998;273:1623-28
31. Barillari G, Gendelman R, Gallo RC, Ensoli B. The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993;90:7941-45
32. Mitola S, Sozzani S, Luini W, et al. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Bood 1997;90:1365-72
33. Albini A, Ferrini S, Benelli R, et al. HIV-1 Tat protein mimicry of chemokines. Immunology 1998;95:13153-58
34. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM. The effects of the Interferon-γ on the central nervous system. Mol Neurobiol 1997;14:119-35
35. Zhang H, Chen X, Teng X, Snead C, Catravas JD. Molecular cloning and analysis of rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem Pharmacol 1998;55: 1873-80
36. Conant K, Ma M, Nath A, Major EO. Extracellular human immunodeficiency virus type 1 tat protein is associated with an increase in both NF-kB binding and protein kinase activity in primary astrocytes. J Virol 1996;70:1384-89
37. Westendorp MO, Shratov VA, Shultze-Osthoff K, et al. HIV-1 tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO J 1995;14:546-54
38. Ott M, Lovetyt Lee, Mueller L, Verdin E. Superinduction of IL-8 in T cells by HIV-1 tat protein is mediated through NF-kB factors. J Immunol 1998;160:2872-80
39. Taylor JP, Pomerantz RJ, Oakes JW, Khalili K, Amini S. A CNS-enriched factor that binds to NF-kB and is required for interaction with HIV-1 tat. Oncogene 1995;10:395-400
40. Cheng H, Tarnok J, Parks WP. Human immunodeficiency virus type 1 genome activation induced by human T cell leukemia virus type 1 tax protein is through cooperation of NF-kB and tat. J Virol 1998;72:6911-16
41. Barton CH, Biggs TE, Mee TR, Mann DA. The human immunodeficiency virus type 1 regulatory protein tat inhibits interferon-induced iNOS activity in a murine macrophage cell line. J Gen Virol 1996;77:1643-47
42. Guastadisegni C, Minghetti L, Nicolini A, et al. Prostaglandin E2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells. FEBS Lett 1997;413:314-18
43. De Simone R, Levi G, Aloisi F. Interferon γ gene expression in rat central nervous system glial cells. Cytokine 1998;10:418-22